Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: 6 INHIBITORS, . Treffer: 4
2022
Suppan, C
ESMO 2021-my top three abstracts in breast cancer
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00810-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Turkovic, L; Bockor, L; Ekpenyong, O; Silovski, T; Lovric, M; Crnkovic, S; Nigovic, B; Sertic, M
Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment
PHARMACEUTICALS-BASE. 2022; 15(5): 614
Doi: 10.3390/ph15050614
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Birnhuber, A; Egemnazarov, B; Biasin, V; Bonyadi Rad, E; Wygrecka, M; Olschewski, H; Kwapiszewska, G; Marsh, LM
CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis.
Respir Res. 2020; 21(1):167-167
Doi: 10.1186/s12931-020-01433-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Thomas, G; Betters, JL; Lord, CC; Brown, AL; Marshall, S; Ferguson, D; Sawyer, J; Davis, MA; Melchior, JT; Blume, LC; Howlett, AC; Ivanova, PT; Milne, SB; Myers, DS; Mrak, I; Leber, V; Heier, C; Taschler, U; Blankman, JL; Cravatt, BF; Lee, RG; Crooke, RM; Graham, MJ; Zimmermann, R; Brown, HA; Brown, JM
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome.
Cell Rep. 2013; 5(2):508-520
Doi: 10.1016/j.celrep.2013.08.047
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG